Testing Ultraprocessed Food Labels in Chile
Evaluating the Effectiveness of an Ultraprocessed Food Warning Label in Chile
1 other identifier
interventional
3,645
1 country
1
Brief Summary
The goal of this experiment is to examine the effects of a warning label signaling that a product is ultraprocessed among a sample of Chilean parents. The main questions this experiment aims to answer are: Do ultraprocessed warning labels on their own impact product purchase intentions? Do ultraprocessed warning labels impact product purchase intentions in the presence of nutrient warning labels? Do ultraprocessed warning labels help more consumers identify ultraprocessed foods? Participants will be randomly assigned to a control arm or an ultraprocessed warning label arm. In both arms, products will carry nutrient warning labels, which are Chile's current policy. Participants will see three similar products, all of which will be ultraprocessed: one not high in any nutrients of concern, one high in sodium, and one high in sodium and saturated fat. For each product, participants will rate their purchase intentions and indicate whether they believe the product to be ultraprocessed. Researchers will compare results across arms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 18, 2025
CompletedFirst Posted
Study publicly available on registry
February 24, 2025
CompletedStudy Start
First participant enrolled
July 14, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2025
CompletedSeptember 9, 2025
April 1, 2025
2 months
February 18, 2025
September 5, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Purchase intentions, mean score
How likely the participant would be to buy products will be measured by survey. Response options will be on a 5-point scale from "very unlikely" (coded as 1) to "very likely" (coded as 5), with higher scores representing a higher likelihood of buying products.
During exposure to intervention (i.e., study stimuli), assessed during one-time online 10-minute survey.
Correct identification of products as ultraprocessed
Correct identification of products as ultraprocessed will be measured by survey. Response will be coded in a dichotomous 0-1 range, where 1 indicates that the participant correctly identified the products as ultraprocessed and 0 indicates that the participant did not correctly identify the products as ultraprocessed.
During exposure to intervention (i.e., study stimuli), assessed during one-time online 10-minute survey.
Secondary Outcomes (1)
Perceived product healthfulness, mean score
During exposure to intervention (i.e., study stimuli), assessed during one-time online 10-minute survey.
Study Arms (2)
Control
ACTIVE COMPARATORUltraprocessed warning label
EXPERIMENTALInterventions
Products do not carry ultraprocessed warning label. To match the current Chilean legislation, products carry octagonal nutrient labels when applicable.
Products carry ultraprocessed warning label. To match the current Chilean legislation, products carry octagonal nutrient labels when applicable.
Eligibility Criteria
You may qualify if:
- years or older
- Parent or guardian of child between 2-14 years old who has never been diagnosed with diabetes, high blood sugar, pre-diabetes or insulin resistance
- Residing in Chile
You may not qualify if:
- Less than 18 years old
- Not parent or guardian of child between 2-14 years old who has never been diagnosed with diabetes, high blood sugar, pre-diabetes or insulin resistance
- Not residing in Chile
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The University of North Carolina at Chapel Hill's Gillings School of Global Public Health
Chapel Hill, North Carolina, 27599, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Aline D'Angelo Campos, MPP
University of North Carolina, Chapel Hill
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 18, 2025
First Posted
February 24, 2025
Study Start
July 14, 2025
Primary Completion
August 31, 2025
Study Completion
August 31, 2025
Last Updated
September 9, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- The Study Protocol and statistical analysis plan will be available by March 2025 (prior to data collection). A de-identified version of the data collected and analytic code used will become available after data collection and analysis and will remain available indefinitely.
- Access Criteria
- Open access.
The Study Protocol and Statistical Analysis Plan will be shared prior to data collection. After data collection and analysis, a de-identified version of individual participant data and the analytic code will be shared through the Open Science Framework (OSF).